IDEAYA Biosciences (IDYA) Financials: Revenue & Earnings
IDYA$32.89-1.07 -3.15%
$3.17B
Market Cap
-18.08
P/E
102.78
Forward P/E
—
Score
IDEAYA Biosciences (IDYA) Financials: Revenue & Earnings
IDYA price $32.89 -1.07 -3.15%
- Ticker
- IDYA
- Price
- $32.89
- Change
- -1.07 -3.15%
- Market cap ?
- $3.17B
- P/E ?
- -18.08
- Forward P/E ?
- 102.78
- Dividend yield ?
- 0.00%
- Beta ?
- -0.09
- Sector
- Healthcare
- Industry
- Biotechnology
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 19538000 | 27941000 | 50931000 | 23385000 | 7000000 | 218710000 |
IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs. IDE397, a methionine adenosyltransferase 2a…
Earnings and financials
IDEAYA Biosciences, Inc. (IDYA) trades at $32.89, with a market cap of $3.17B and a trailing P/E of -18.08. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 19538000 | 27941000 | 50931000 | 23385000 | 7000000 | 218710000 |
Insights · Dividends · Forecast · Financials · Learn